Recurring Meeting of the Advisory Board

Date(s): October 28 - November 1, 2013

Due to scheduling conflicts, the group meeting with the Advisory Board members were scheduled on an individual basis with each member. Please refer to Meeting Minutes for more details.

TableOfContents

Progress Report

Project Specific Aims

• To provide an open, freely available, and collaborative development, testing, simulation and dissemination platform for in silico exploration of the biomechanics of healthy and diseased knees.
• To develop in silico biomechanical models of healthy and diseased knee joints of different genders and ages, supported by specimen-specific joint and tissue level experimental mechanics.

Project Infrastructure

• https://simtk.org/home/openknee (project website)

• http://wiki.simtk.org/openknee (project wiki)

Project Contact

• Ahmet Erdemir, PhD, erdemira@ccf.org, https://simtk.org/users/aerdemir

Advisory Board

• Clinical. Jack Andrish, MD; Carl Winalski, MD; Morgan Jones, MD, MPH; Paul Saluan, MD (Cleveland Clinic)

• Engineering. Yasin Dhaher, PhD (Northwestern University); Trent Guess, PhD (University of Missouri), Rami Korhonen, PhD (University of Eastern Finland)

Progress Period

• September 16, 2013 - October 28, 2013

Goals of Progress Period

• TBD.

Development Team during Progress Period

• Cleveland Clinic Core Team. Craig Bennetts, Tara Bonner, Snehal Chokhandre, Robb Colbrunn, Ahmet Erdemir, Jason Halloran

• Stanford University. Scott Delp, Joy Ku, Henry Kwong

• University of Utah. Ben Ellis, Jeff Weiss, Steve Maas

• Community. Scott Sibole

See https://simtk.org/project/xml/team.xml?group_id=485 for full details on the project team.

Accomplishments of Current Progress Period

• TBD

Plans for Next Progress Period

• TBD

Meeting Minutes

Date:

Time:

Means:

Attendees:

1. TBD

Agenda:

1. Project description
2. Expectations from Advisory Board
3. Progress update
4. Scheduling of biannual meetings
5. Action items for following meeting
6. Other

Immediate Action Items:

See notes for details.

• TBD

Notes:

1. TBD